Why Is Moderna Stock Hitting Another Record High Today? As of 11:10 a.m., shares of Moderna (NASDAQ: MRNA) were up 4.3 percent. EDT on Thursday, the stock reached a new all-time high. The boost came when Jefferies analyst Michael Yee raised his price objective for the stock from $170 to $250. In a news conference, Dr. Marco Cavaleri, the head of the European Medicines Agency’s (EMA) biological health threats and vaccines strategy, said that a committee will likely make a decision on recommending authorization for Moderna’s COVID-19 vaccine in children by the end of next week./n
Read More
